Showing results (291-300 of 1,274) with videos related to

Sort By:
Pageof 128
Clinical Colorectal Cancer|June 15, 2024
Explanatory Role of Conversion Surgery as a Mediator of the Mortality Risk Difference Between Patients With Unresectable Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR Agents Versus BevacizumabChien-Chou Su, Yi-Chia Su, Chih-Chien Wu, et al.
Clinical Colorectal Cancer|November 24, 2025
Estrogen Receptor May Play Important Role in Gender Differences of Early-Onset Colorectal CancerQian-Nan Wang, Xiao Zhang, Lan-Lan Feng, et al.
Clinical Colorectal Cancer|April 23, 2024
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and EEric X Chen, Petr Kavan, Mustapha Tehfe, et al.
Clinical Colorectal Cancer|January 12, 2024
Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality TherapyEthan P Damron, Jordan McDonald, Michael K Rooney, et al.
Clinical Colorectal Cancer|June 19, 2026
Resource Use and Costs of the Low-risk Arm of a Risk-stratified Colorectal Cancer Screening Approach Based on Previous Negative FIT Values: Comparative Analyses With the Standard ApproachAndrea Buron, Merce Comas, Carmen Guirado-Fuentes, et al.
Clinical Colorectal Cancer|July 27, 2026
Colorectal Cancer Screening at Younger Ages: A Multicutoff Analysis of FIT PerformanceJulia Hibbert, Teresa Seum, Michael Hoffmeister, et al.
Clinical Colorectal Cancer|September 21, 2026
Efficacy and Safety of Immune Checkpoint Inhibitor-Based Neoadjuvant Therapy Combinations in Proficient Mismatch Repair/Microsatellite Stable Locally Advanced Rectal Cancer: A Systematic Review and Meta-AnalysisXiya Jia, Guoyou Zhang, Yiming Lv, et al.
Clinical Colorectal Cancer|October 26, 2026
AZUR-4, a Phase 2, Open Label, Randomized Study of Neoadjuvant Dostarlimab Plus CAPEOX Versus CAPEOX in Previously Untreated T4N0 or Stage III Mismatch Repair Proficient/Microsatellite Stable Resectable Colon CancerGertjan Rasschaert, Allyson M Peddle, Sara Verbandt, et al.
Clinical Colorectal Cancer|October 22, 2026
Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab as Third-Line Treatment in Circulating Tumor DNA-Selected Metastatic Colorectal Cancer (ROMANCE Trial)Alessandra Pia D'Agata, Gloria Pellizzari, Giulia Martini, et al.
Clinical Colorectal Cancer|November 23, 2022
Sarcopenia is Associated With Oncological Prognosis and the Incidence of Secondary Cancer in Patients With Middle/Lower Rectal CancerShinya Abe, Hiroaki Nozawa, Kazuhito Sasaki, et al.
Pageof 128